| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Conversion Labs (NASDAQ:CVLB) shares are trading higher Monday after Capital Market Laboratories (CML Pro) on Saturday added the company as a company to watch. Citron Research also said said it was long CVLB "and said it's "[n]ew presentation [is] compelling."
Conversion Labs is a health and wellness-focused e-commerce company with a portfolio of online direct-to-consumer brands. The company's portfolio of brands includes proprietary over-the-counter products as well as prescription medications. The company also provides online physician consultations directly to consumers.
Conversion Labs shares were trading up 13.64% at $23.66. The stock has a 52-week high of $25.51 and a 52-week low of 50 cents.
Posted In: CVLB
